Slideshow

Saturday, October 11

7:30 am - 5:30 pm

Registration Open

7:30 am - 8:30 am

Preconference Continental Breakfast

Available for registrants of sessions 080 and 090.

8:30 am - 12:00 nn

Optional Half-Day Preconference Workshops (080-090)

Separate registration fee required (see fees).

080

Evidence-Based Practice: Clinical Applications

3.25 CH

Debra Hain, PhD, APRN, ANP-BC, GNP-BC
Mary Haras, PhD, MS, MBA, APN, NP-C, CNN

  • Develop a nephrology-based PICOT question, which includes defining a problem, a suggested intervention, evaluating a comparison intervention, and determining the outcome to be accomplished that is being sought over a time frame.
  • Recognize sources of evidence and their levels of importance.
  • Review examples of clinical applications of evidencebased practice in nephrology.

090

Trends in Pharmacology: Medicare Part D/Medical Marijuana

3.25 CH 2.0 Rx

Wendy St. Peter, PharmD, FCCP, FASN, FNKF
Laura Borgelt, PharmD, FCCP, BCPS, NCMP

  • Compare and contrast regulatory issues for use of marijuana in various states.
  • Describe the clinical pharmacology, dosage forms, pharmacodynamic impact, therapeutic and adverse effects, drug interactions, and consumer safety issues of marijuana use.
  • Describe the development of Medicare Part D, its future, and the potential impact of the dialysis "bundle" on patients and providers.
  • Examine trends in medication use in CKD and ESRD patients enrolled in Medicare Part D and overall costs of the program for these patients.

12:00 nn - 1:30 pm

Lunch on your own*

*Registrants will be notified if a corporate-supported symposium is offered during this time slot.

1:30 pm - 2:45 pm

General Session

101

A Retrospective Look at Highlights of Federal Government Policy Toward Treatment of End-Stage Renal Disease

1.25 CH

Richard Rettig, PhD

  • Outline the historical path of regulation of care of individuals with kidney disease.
  • Relate the impact of regulations on care of individuals with kidney disease.
  • Develop a personal picture of the future of care for individuals with kidney disease and the role regulation will play in that scenario.

2:45 pm - 3:00 pm

Stretch Break

3:00 pm - 4:15 pm

General Session

102

Impact of Regulations ~ Renal Pharmacy: Medications and Dosing

1.25 CH.5 Rx

Cheryl Gilmartin, PharmD

  • Compare and contrast previous pharmacology medications and orders with changes related to the implementation of renal pharmacies.
  • Relate and provide examples of changes that have occurred in prescribing practices.
  • Identify an example of how renal pharmacies will impact drug management on a specific process such as bone mineral density.

4:30 pm - 6:30 pm

Exhibits Open / Reception in Exhibit Hall

> View the schedule for Friday View the schedule for Sunday >